Idexx Laboratories
IDXX
748 hedge funds and large institutions have $18.4B invested in Idexx Laboratories in 2020 Q1 according to their latest regulatory filings, with 88 funds opening new positions, 244 increasing their positions, 291 reducing their positions, and 93 closing their positions.
29% more funds holding in top 10
Funds holding in top 10: 14 → 18 (+4)
2.45% more ownership
Funds ownership: 86.89% → 89.34% (+2.4%)
5% less first-time investments, than exits
New positions opened: 88 | Existing positions closed: 93
2% less funds holding
Funds holding: 760 → 748 (-12)
5% less capital invested
Capital invested by funds: $19.5B → $18.4B (-$1.03B)
16% less repeat investments, than reductions
Existing positions increased: 244 | Existing positions reduced: 291
23% less call options, than puts
Call options by funds: $30.3M | Put options by funds: $39.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$291M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$196M |
| 3 |
Select Equity Group
New York
|
+$183M |
| 4 |
BlackRock
New York
|
+$116M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$106M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$333M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$94.3M |
| 3 |
Fundsmith LLP
London,
United Kingdom
|
-$90.5M |
| 4 |
Renaissance Technologies
New York
|
-$75.4M |
| 5 |
BAMCO Inc
New York
|
-$59.5M |
IDXX Hedge Fund Activity: Q1 2020 in Review
748 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q1 2020, worth a combined $18.4B — down 5.3% from $19.5B a quarter earlier.
Sellers outnumbered buyers: 93 funds closed out of IDXX and 88 opened new positions — a net loss of 5 holders — while 291 trimmed existing stakes and 244 added.
The largest buyer was AllianceBernstein, adding an estimated $291M. The largest seller was T. Rowe Price Associates, cutting an estimated $333M.
- 748 institutional investors held Idexx Laboratories (IDXX) as of Q1 2020, down from 760 in Q4 2019.
- Funds reported $18.4B of Idexx Laboratories stock for Q1 2020, down 5.3% quarter-over-quarter.
- 88 funds opened new Idexx Laboratories positions in Q1 2020 and 93 closed out, a net change of -5 holders.
- The largest Idexx Laboratories buyer in Q1 2020 was AllianceBernstein, an estimated $291M added.
- The largest Idexx Laboratories seller in Q1 2020 was T. Rowe Price Associates, an estimated $333M sold.
Based on aggregated 13F filings for Q1 2020.